Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer That Overexpresses HER2
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Trastuzumab
Related studies linked through entity extraction aliases.
Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothelium
- Status
- TERMINATED
- Phase
- PHASE2
Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Paclitaxel With or Without Trastuzumab Following Peripheral Stem Cell Transplantation in Treating Patients With Refractory Stage IV Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Monoclonal Antibody Plus Chemotherapy in Treating Patients With Advanced Colorectal Cancer That Overexpresses HER2
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2
- Status
- COMPLETED
- Phase
- PHASE2
Trastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas
- Status
- UNKNOWN
- Phase
- PHASE2
Trastuzumab in Treating Patients With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy and Trastuzumab in Treating Women With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Paclitaxel Plus Monoclonal Antibody Therapy in Treating Women With Recurrent or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic
- Status
- COMPLETED
- Phase
- PHASE3